Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06454578
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-06-06
Brief Title:
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
Sponsor:
Qilu Hospital of Shandong University
Organization:
Qilu Hospital of Shandong University
Organization Data
Organization:
Qilu Hospital of Shandong University
Class:
OTHER
Study ID:
KYLL-202401-002-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Qilu Hospital of Shandong University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None